lamivudine (Epivir-HBV)

Small molecule

Approvedregulatory verdict

Evidence outlook

Approved: Chronic Hepatitis B

Regulatory approval supersedes design-level evidence grading; the trials behind approval are preserved below as the drug's evidence history.

US marketing discontinued: Drugs@FDA lists every US product of this approval as discontinued.

Every registered study for this drug was reviewed, and none was selected as featured evidence for its approved use, so its Featured trials section is empty.

Also approved (1)
EU
  • Chronic hepatitis B in adults with compensated or decompensated liver disease (EU brand Zeffix, same 100 mg lamivudine HBV product, GlaxoSmithKline)
Product first approved 1999EMA

How the evidence outlook works ↗

All registered studies

Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase. Studies where this drug served as another program's comparator, or is merely referenced, are listed separately below.

Phase 3 (126)
Chronic Hepatitis B
NCT01848743 · Kaohsiung Veterans General Hospital.
2013-04 – 2016-10 · Chronic HBV With Severe Exacerbation
What this study did
NCT01095835 · Hoffmann-La Roche
2005-02 – 2010-01 · Hepatitis B, Chronic
What this study did
NCT00140725 · GlaxoSmithKline
started 2000-04 · Chronic Hepatitis B
What this study did
NCT00120796 · French National Agency for Research on AIDS and Viral Hepatitis
2005-08 – 2008-07 · Hepatitis B
What this study did
NCT00275652 · Mayo Clinic
2004-06 – 2007-08 · Hepatitis B, Cirrhosis
What this study did
NCT00131742 · Novartis
2004-07 – 2007-01 · Chronic Hepatitis B
What this study did
NCT00132652 · Novartis
2005-02 – 2006-12 · Chronic Hepatitis B
What this study did
NCT00057265 · Novartis
2003-02 – 2006-04 · Chronic Hepatitis B
What this study did
Other / comorbidity
NCT07393659 · ViiV Healthcare
2026-07-21 – 2032-09-14 · HIV Infections
What this study did
NCT07792096 · University College, London
2026-11 – 2029-12 · HIV Infection
What this study did
NCT06497465 · Johns Hopkins University
2025-09-18 – 2029-01-31 · Tuberculosis, HIV
What this study did
NCT06203132 · ANRS, Emerging Infectious Diseases
2025-01-27 – 2029-01 · HIV-1-infection
What this study did
NCT07075146 · José Antonio Mata Marín
2025-05-05 – 2028-08-01 · HIV - Human Immunodeficiency Virus, Obesity, Overweight and/or Obesity
What this study did
NCT06444620 · University of Nairobi
2024-07-22 – 2026-07-23 · HIV-1-infection
What this study did
NCT05193994 · Macquarie University, Australia
2022-02-24 – 2025-06-30 · Amyotrophic Lateral Sclerosis
What this study did
NCT06658977 · Macquarie University, Australia
2024-11-15 – 2025-06-03 · Amyotrophic Lateral Sclerosis, ALS
What this study did
NCT03682848 · ViiV Healthcare
2019-05-06 – 2025-05-22 · HIV Infections
What this study did
NCT04022967 · ANRS, Emerging Infectious Diseases
2020-11-17 – 2024-12-30 · HIV-1-infection
What this study did
NCT03016533 · ViiV Healthcare
2017-06-06 – 2024-12-24 · HIV Infections
What this study did
NCT04979468 · Societa' Italiana Di Malattie Infettive E Tropicali
2021-03-23 – 2024-04-01 · HIV-1-infection
What this study did
NCT04808973 · Fundação Bahiana de Infectologia
2021-07-01 – 2023-09-10 · HIV Infections, Pregnancy Related, Mother to Child Transmission
What this study did
NCT02403674 · Merck Sharp & Dohme LLC
2015-06-05 – 2023-09-07 · Human Immunodeficiency Virus (HIV)
What this study did
NCT04034862 · University of Liege
2019-10-01 – 2023-06-30 · HIV Infections
What this study did
NCT05457530 · Prism Health North Texas
2022-08-01 – 2023-05-03 · Body Weight Changes, Human Immunodeficiency Virus, ART, Obesity, Minority Health, BMD, Metabolic Syndrome, Fasting
What this study did
NCT04433780 · Professor Francois Venter
2021-01-04 – 2023-03-31 · HIV-1-infection
What this study did
NCT03870438 · ANRS, Emerging Infectious Diseases
2019-12-14 – 2022-10-31 · HIV-1
What this study did
NCT01910402 · ViiV Healthcare
2013-08-22 – 2022-08-18 · Infection, Human Immunodeficiency Virus, HIV Infections
What this study did
NCT02831673 · ViiV Healthcare
2016-07-21 – 2022-08-15 · Infection, Human Immunodeficiency Virus, HIV Infections
What this study did
NCT02831764 · ViiV Healthcare
2016-07-18 – 2022-06-29 · Infection, Human Immunodeficiency Virus, HIV Infections
What this study did
NCT03446573 · ViiV Healthcare
2018-01-18 – 2022-05-03 · HIV Infections
What this study did
NCT03988452 · Makerere University
2019-07-30 – 2021-09-30 · Human Immunodeficiency Virus
What this study did
NCT02075593 · ViiV Healthcare
2014-12-17 – 2021-09-15 · Infection, Human Immunodeficiency Virus, HIV Infections, Arthralgia
What this study did
NCT02777229 · ANRS, Emerging Infectious Diseases
2016-07 – 2021-07 · HIV-1 Infection
What this study did
NCT03563742 · Janssen Research & Development, LLC
2018-09-24 – 2021-06-28 · Human Immunodeficiency Virus Infections
What this study did
NCT03945981 · ViiV Healthcare
2019-07-02 – 2020-10-20 · HIV Infections
What this study did
NCT02231281 · Yongtao Sun, MD, PhD
2014-08 – 2018-12 · Acute HIV Infection
What this study did
NCT02273765 · ANRS, Emerging Infectious Diseases
2015-09-11 – 2018-11-28 · HIV-1 Infection, Tuberculosis
What this study did
Phase 2/3 (8)
Other / comorbidity
NCT02369406 · Harvard School of Public Health (HSPH)
2015-05-04 – 2029-06-30 · HIV, Pediatric AIDS
What this study did
NCT05517434 · University Health Network, Toronto
2025-01-01 – 2028-12 · Osteoarthritis, Knee
What this study did
NCT04337450 · PENTA Foundation
2022-04-22 – 2026-09-30 · HIV Infections
What this study did
NCT02150993 · ANRS, Emerging Infectious Diseases
2016-01-26 – 2019-05-15 · HIV-2 Infection
What this study did
NCT01656122 · The HIV Netherlands Australia Thailand Research Collaboration
2012-07 – 2015-07 · HIV
What this study did
NCT01127204 · ANRS, Emerging Infectious Diseases
2011-06 – 2015-04 · HIV Infections
What this study did
NCT00039741 · National Institute of Allergy and Infectious Diseases (NIAID)
2002-08 – 2010-03 · HIV Infections
What this study did
NCT00272480 · Imperial College London
1999-11-08 – 2002-07-30 · HTLV-I-associated Myelopathy
What this study did
Phase 2 (96)
Chronic Hepatitis B
NCT01125696 · Centers for Disease Control and Prevention
2012-05 – 2018-08 · HIV, Hepatitis B
What this study did
NCT01914744 · Fudan University
2013-02 – 2016-12 · Non-Hodgkin Lymphoma, Hepatitis B Reactivation
What this study did
NCT00023309 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
2001-08 – 2013-08 · HBV (Hepatitis B Virus), Hepatitis B, Hepatitis
What this study did
NCT01438424 · Bristol-Myers Squibb
2001-01 – 2011-04 · Hepatitis B Virus, HBV
What this study did
NCT00226447 · Chinese University of Hong Kong
2002-12 – 2006-07 · Chronic Hepatitis B
What this study did
NCT00124241 · Novartis
est. completion 2005-11 · Hepatitis B
What this study did
NCT00201318 · National Health Research Institutes, Taiwan
2001-09 – 2005-10 · Non-Hodgkin's Lymphoma
What this study did
NCT00001457 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
1995-09 – 2005-09 · Chronic Hepatitis B, Chronic Hepatitis D, Glomerulonephritis, Polyarteritis Nodosa
What this study did
NCT00040144 · Alexion Pharmaceuticals, Inc.
2002-07 – 2003-05 · Chronic Hepatitis B
What this study did
NCT00034359 · Alexion Pharmaceuticals, Inc.
2002-02 – 2003-01 · Hepatitis B, Chronic
What this study did
Other / comorbidity
NCT04375800 · Merck Sharp & Dohme LLC
2021-02-03 – 2034-04-11 · Human Immunodeficiency Virus (HIV) Infection
What this study did
NCT06356740 · Hospices Civils de Lyon
2024-09-01 – 2029-06-01 · Systemic Lupus Erythematosus
What this study did
NCT06774872 · Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida
2025-04-30 – 2028-06-15 · HIV-1-infection
What this study did
NCT07640503 · Maria Denise Fernandes Carvalho de Andrade
2025-11-05 – 2027-12 · Rett Syndrome
What this study did
NCT04696575 · Roswell Park Cancer Institute
2021-07-02 – 2027-07-01 · Extensive Stage Lung Small Cell Carcinoma
What this study did
NCT06034938 · University Hospital, Caen
2024-02-08 – 2026-05-01 · Hiv
What this study did
NCT06519357 · Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
2024-10-28 – 2026-03 · Mild Cognitive Impairment
What this study did
NCT04880785 · Fundacion SEIMC-GESIDA
2021-07-28 – 2024-04-09 · HIV Infections
What this study did
NCT04731103 · University of Edinburgh
2022-08-24 – 2024-03-11 · Aicardi-Goutières Syndrome
What this study did
NCT02652260 · Merck Sharp & Dohme LLC
2016-03-04 – 2024-02-07 · HIV-1, Central Nervous System
What this study did
NCT04871113 · ViiV Healthcare
2021-06-22 – 2023-09-21 · HIV Infections
What this study did
NCT04493216 · ViiV Healthcare
2020-11-18 – 2023-05-29 · HIV Infections
What this study did
NCT03144804 · Massachusetts General Hospital
2017-10-31 – 2022-09-27 · Colorectal Cancer Metastatic
What this study did
NCT03272347 · Merck Sharp & Dohme LLC
2017-11-27 – 2022-03-09 · HIV-1 Infection
What this study did
NCT03869944 · ANRS, Emerging Infectious Diseases
2019-12-04 – 2022-03 · HIV-1
What this study did
NCT03539224 · Instituto de Investigación Hospital Universitario La Paz
2017-11-02 – 2021-07-31 · HIV-1-infection
What this study did
NCT03549689 · Philip Grant
2019-08-01 – 2021-07-01 · HIV/AIDS, HIV-1-infection, Osteopenia
What this study did
NCT02363452 · Assistance Publique - Hôpitaux de Paris
2015-09-10 – 2018-06 · Aicardi-Goutières Syndrome (AGS)
What this study did
NCT02750059 · SEARCH Research Foundation
2015-01 – 2018-02 · Acute HIV Infection, HIV CNS Involvement
What this study did
NCT02582684 · Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
2015-12-08 – 2017-09-26 · HIV-1 Infection
What this study did
NCT02566707 · Radboud University Medical Center
2015-08 – 2016-12 · HIV-1 Infection
What this study did
NCT00307151 · International Maternal Pediatric Adolescent AIDS Clinical Trials Group
2005-12 – 2016-12 · HIV Infections
What this study did
NCT01160120 · The HIV Netherlands Australia Thailand Research Collaboration
2010-06 – 2015-06 · HIV
What this study did
NCT00001094 · National Institute of Allergy and Infectious Diseases (NIAID)
— · HIV Infections
What this study did
NCT01489046 · Bristol-Myers Squibb
2011-02 – 2014-07 · HIV-1 Infection
What this study did
NCT00146380 · Centers for Disease Control and Prevention
2003-07 – 2013-01 · HIV Infections
What this study did
NCT00099632 · National Institute of Allergy and Infectious Diseases (NIAID)
2006-03 – 2011-11 · HIV Infections
What this study did
NCT00915655 · Tibotec Pharmaceuticals, Ireland
2009-07 – 2011-03 · HIV-1 Infection
What this study did
NCT00943540 · Radboud University Medical Center
2009-07 – 2011-01 · HIV Infection, HIV Infections
What this study did
NCT00958100 · Catholic University of the Sacred Heart
2009-08 – 2010-12 · HIV/AIDS, Antiretroviral Therapy, HIV Infections
What this study did
NCT00270296 · National Institute of Allergy and Infectious Diseases (NIAID)
2006-06 – 2010-09 · HIV Infections
What this study did
NCT00100048 · Merck Sharp & Dohme LLC
2005-01 – 2010-07 · HIV Infections, Acquired Immunodeficiency Syndrome
What this study did
NCT00122538 · French National Agency for Research on AIDS and Viral Hepatitis
2006-02 – 2009-05 · HIV Infections, AIDS
What this study did
NCT00380159 · Alexion Pharmaceuticals, Inc.
2006-09 – 2009-01 · Human Immunodeficiency Virus (HIV)-1 Infection
What this study did
Phase 1/2 (11)
Other / comorbidity
Lamivudine for Solid Tumorsactive not recruiting
NCT06494579 · Thomas Marron
2024-09-26 – 2027-09-30 · Relapsed/Refractory Solid Tumors
What this study did
NCT04552795 · The University of Texas Health Science Center at San Antonio
2021-02-15 – 2023-11-04 · Alzheimer Disease, Early Onset
What this study did
NCT03760458 · National Institute of Allergy and Infectious Diseases (NIAID)
2020-09-09 – 2022-05-31 · HIV Infections
What this study did
NCT03332095 · National Institute of Allergy and Infectious Diseases (NIAID)
2018-07-02 – 2022-05-25 · HIV Infections
What this study did
NCT03836833 · Drugs for Neglected Diseases
2019-06-04 – 2019-12 · HIV
What this study did
NCT01528865 · University of Michigan Rogel Cancer Center
2015-12 – 2017-08 · Lymphoma
What this study did
NCT00985647 · Kirby Institute
2009-12 – 2010-03 · HIV Infections
What this study did
NCT00672412 · National Institute of Allergy and Infectious Diseases (NIAID)
2008-10 – 2010-01 · HIV Infections
What this study did
NCT00312091 · National Institute of Allergy and Infectious Diseases (NIAID)
2006-12 – 2008-09 · HIV Infections
What this study did
NCT00004578 · Abbott
1997-11 – 2005-04 · HIV Infections
What this study did
Phase 1 (43)
Chronic Hepatitis B
NCT01353742 · GlaxoSmithKline
2011-02-21 – 2011-04-12 · Hepatitis B, Chronic
What this study did
Other / comorbidity
NCT06428045 · University of Miami
2025-04-15 – 2030-04-30 · High Grade Glioma
What this study did
NCT07058974 · Icahn School of Medicine at Mount Sinai
2025-08-12 – 2027-06-15 · Smokers, Former Smokers
What this study did
NCT06056596 · University of Wisconsin, Madison
2024-01-30 – 2024-09-06 · Retinal Detachment, Rhegmatogenous Retinal Detachment
What this study did
NCT06811246 · Merck Sharp & Dohme LLC
2024-02-07 – 2024-07-14 · Healthy
What this study did
NCT04283656 · Thomas Jefferson University
2022-01-04 – 2022-12-30 · Transgender Health, Gender Dysphoria, Transgender Women, Human Immunodeficiency Virus
What this study did
NCT04302896 · Rhonda Brand
2020-08-31 – 2021-09-30 · Medication Adherence, HIV
What this study did
NCT05030025 · Mylan Inc.
2021-08-01 – 2021-08-29 · HIV-1-infection
What this study did
NCT02832778 · St Stephens Aids Trust
2016-11-21 – 2018-02 · HIV
What this study did
NCT02499874 · St Stephens Aids Trust
2015-08 – 2017-10-05 · HIV
What this study did
NCT03078556 · ViiV Healthcare
2017-03-27 – 2017-08-18 · Infection, Human Immunodeficiency Virus
What this study did
NCT02893488 · ViiV Healthcare
2016-09-01 – 2016-11-25 · Infection, Human Immunodeficiency Virus
What this study did
NCT02738931 · ViiV Healthcare
2016-05 – 2016-06 · Infection, Human Immunodeficiency Virus
What this study did
NCT02539576 · ViiV Healthcare
2015-10 – 2015-11 · Infection, Human Immunodeficiency Virus
What this study did
NCT02604004 · Universidade Federal de Pernambuco
2013-04 – 2013-12 · HIV INFECTIONS
What this study did
NCT00719602 · International Maternal Pediatric Adolescent AIDS Clinical Trials Group
2009-08 – 2013-08 · HIV Infections, Malaria
What this study did
NCT01622790 · ViiV Healthcare
2012-06 – 2012-08 · Infection, Human Immunodeficiency Virus
What this study did
NCT01469520 · Elim Pediatric Pharmaceuticals Inc.
2010-10 – 2011-12 · HIV, AIDS
What this study did
NCT01366547 · ViiV Healthcare
2011-06 – 2011-07 · Healthy Subjects, Infection, Human Immunodeficiency Virus
What this study did
NCT01220232 · Pfizer
2010-11 – 2011-01 · Healthy Volunteers
What this study did
NCT00001644 · National Institute of Allergy and Infectious Diseases (NIAID)
1997-03-03 – 2010-02-17 · HIV Infection
What this study did
NCT00470041 · University Ghent
2007-06 – 2009-12 · Healthy
What this study did
NCT00004736 · National Institute of Allergy and Infectious Diseases (NIAID)
— · HIV Infections, Tuberculosis
What this study did
NCT00336778 · University of Maryland, Baltimore
2004-01 – 2008-04 · HIV Infections
What this study did
NCT00000887 · National Institute of Allergy and Infectious Diseases (NIAID)
est. completion 2004-07 · HIV Infections, Pregnancy
What this study did
NCT00000952 · National Institute of Allergy and Infectious Diseases (NIAID)
est. completion 2004-01 · HIV Infections
What this study did
NCT00000920 · National Institute of Allergy and Infectious Diseases (NIAID)
est. completion 2003-04 · HIV Infections, Pregnancy
What this study did
NCT00000944 · National Institute of Allergy and Infectious Diseases (NIAID)
est. completion 2003-03 · HIV Infections, Pregnancy
What this study did
NCT00014014 · National Institute of Allergy and Infectious Diseases (NIAID)
est. completion 2002-08 · HIV Infections
What this study did
NCT00000834 · National Institute of Allergy and Infectious Diseases (NIAID)
est. completion 2002-06 · HIV Infections
What this study did
NCT00000902 · National Institute of Allergy and Infectious Diseases (NIAID)
est. completion 2002-04 · HIV Infections
What this study did
NCT00000878 · National Institute of Allergy and Infectious Diseases (NIAID)
est. completion 2001-10 · HIV Infections, Pregnancy
What this study did
NCT00000899 · National Institute of Allergy and Infectious Diseases (NIAID)
est. completion 2001-10 · HIV Infections
What this study did
NCT00000888 · National Institute of Allergy and Infectious Diseases (NIAID)
est. completion 2001-04 · HIV Infections, Pregnancy
What this study did
NCT00001968 · National Institute of Allergy and Infectious Diseases (NIAID)
2000-01 – 2000-11 · Acquired Immunodeficiency Syndrome, HIV Infections
What this study did
NCT00001091 · National Institute of Allergy and Infectious Diseases (NIAID)
est. completion 2000-10 · HIV Infections
What this study did
NCT00000901 · National Institute of Allergy and Infectious Diseases (NIAID)
est. completion 2000-10 · HIV Infections
What this study did
NCT00001108 · National Institute of Allergy and Infectious Diseases (NIAID)
est. completion 2000-06 · HIV Infections
What this study did
NCT00000865 · National Institute of Allergy and Infectious Diseases (NIAID)
est. completion 1998-04 · HIV Infections
What this study did
Phase 4 (126)
Chronic Hepatitis B
NCT02560649 · Ruijin Hospital
2015-05 – 2017-02 · Chronic Hepatitis B
What this study did
NCT00810524 · Sun Yat-sen University
2007-01 – 2017-01 · Hepatitis B, Chronic
What this study did
NCT02337127 · Kaohsiung Medical University Chung-Ho Memorial Hospital
2011-06 – 2016-05 · Chronic Hepatitis B
What this study did
NCT01627223 · Taichung Veterans General Hospital
2012-07 – 2016-04 · Chronic Hepatitis B
What this study did
NCT01005238 · University Hospital, Basel, Switzerland
2009-09 – 2014-12 · Hepatitis, Chronic
What this study did
NCT01546116 · Korea University
2010-02 – 2014-02 · Chronic Hepatitis B
What this study did
NCT02202473 · Southeast University, China
est. completion 2014-02 · Chronic Hepatitis B
What this study did
NCT01788371 · Hua Zhang
2009-03 – 2013-07 · Hepatitis B Infection, Chronic Infection, Viremia
What this study did
NCT01743079 · Beijing YouAn Hospital
2009-01 – 2013-07 · Chronic Hepatitis B, Late Pregnancy, Transmission, Complication
What this study did
NCT01088009 · Nanfang Hospital, Southern Medical University
2010-03 – 2013-05 · Compensated Chronic Hepatitis B
What this study did
NCT00531167 · Korea University
2007-04 – 2012-10 · Chronic Hepatitis B
What this study did
NCT00798460 · Inje University
2008-12 – 2010-11 · Chronic Hepatitis B
What this study did
NCT00768157 · Sun Yat-sen University
2007-04 – 2010-08 · Hepatocellular Carcinoma, Hepatitis B Virus, Recurrence
What this study did
NCT00662545 · University of California, San Francisco
2008-04 – 2010-05 · HIV Infections, Hepatitis B
What this study did
NCT00230477 · University of Washington
2003-04 – 2007-08 · Hepatitis B
What this study did
NCT00120354 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
2005-07-11 – 2007-03-31 · Hepatitis B, Chronic
What this study did
NCT00354653 · ViiV Healthcare
2002-02-09 – 2007-01-23 · CHRONIC HEPATITIS B
What this study did
NCT00380614 · Maulana Azad Medical College
2002-01 – 2005-03 · Hepatitis B
What this study did
NCT00338780 · Chinese University of Hong Kong
2000-11 – 2005-01 · Chronic Hepatitis B
What this study did
Other / comorbidity
NCT07031063 · Instituto Mexicano del Seguro Social
2025-04-01 – 2028-12-01 · HIV Infection, Metabolic Syndrome, Antiretroviral Treatment
What this study did
NCT07631897 · Shanghai Public Health Clinical Center
2026-06 – 2028-12 · HIV, Art Therapy, TB - Tuberculosis
What this study did
NCT07616739 · Fundación Huésped
2026-09-10 – 2028-10-15 · HIV-1-infection
What this study did
NCT07357584 · Fundación Huésped
2026-09-16 – 2028-04-30 · HIV-1-infection
What this study did
NCT07673965 · University of Witwatersrand, South Africa
2026-10-05 – 2027-11-30 · HIV (Human Immunodeficiency Virus), Sleep
What this study did
NCT06580873 · Saskatchewan Health Authority - Regina Area
2024-09-30 – 2027-10-31 · HIV-1-infection, Opioid Use Disorder
What this study did
B-free Multistage Trialenrolling by invitation
NCT06037564 · Insel Gruppe AG, University Hospital Bern
2023-11-13 – 2027-09 · HIV, Drug Resistance, Drug Drug Interaction
What this study did
NCT06503796 · Beijing 302 Hospital
2024-08 – 2026-11 · HBV
What this study did
NCT06485154 · University of Witwatersrand, South Africa
2024-06-01 – 2026-08-31 · HIV Prevention
What this study did
NCT05493969 · Shanghai Public Health Clinical Center
2022-08 – 2026-06 · Acquired Immunodeficiency Syndrome
What this study did
NCT07006246 · Professor Francois Venter
2023-05-19 – 2025-11-30 · HIV Infection
What this study did
NCT06602622 · Instituto Mexicano del Seguro Social
2024-08-14 – 2025-11-14 · HIV, HIV Associate Weight Loss, HIV-1 Infection, Integrase Inhibitors, HIV; HIV PROTEASE INHIB, Weight Change, Weight Loss
What this study did
NCT04884139 · Fundacion SEIMC-GESIDA
2021-07-14 – 2025-03-13 · HIV-1-infection
What this study did
NCT04880395 · Fundación Huésped
2021-05-17 – 2024-05-07 · HIV-1-infection
What this study did
NCT04665375 · University Health Network, Toronto
2021-04-26 – 2024-03-31 · Hiv, Weight Gain
What this study did
NCT03675815 · Kirby Institute
2019-12-05 – 2024-01-15 · HIV Infections
What this study did
NCT04826562 · Saint Michael's Medical Center
2021-09-26 – 2023-12-30 · Human Immunodeficiency Virus
What this study did
NCT04904406 · Thomas Benfield
2020-10-22 – 2023-12-01 · Hiv, HIV Infections, HIV Cardiomyopathy, Weight Change, Body, HIV Lipodystrophy, Cardiovascular Diseases
What this study did
NCT04549467 · Fundacion IDEAA
2020-11-17 – 2023-09-30 · Hiv, HIV-1-infection
What this study did
NCT07014189 · Cantonal Hospital of St. Gallen
2019-04-12 – 2023-08-31 · HIV Infection, Antiretroviral Treatment, Maintenance Therapy
What this study did
NCT04585737 · Charlotte-Paige Rolle, MD
2020-10-05 – 2023-08-10 · HIV I Infection
What this study did
NCT04903847 · Thomas Benfield
2021-02-02 – 2023-02-02 · Hiv, HIV Infections, HIV Lipodystrophy, Osteoporosis, Renal Insufficiency, Weight Gain, Obesity
What this study did
NCT05295394 · Pedro Cahn
2019-05-22 – 2022-08-30 · HIV-1 Infection
What this study did
NCT02712801 · National Center for Women and Children's Health, China CDC
2016-04 – 2021-12 · HIV/AIDS and Infections
What this study did
NCT02659761 · University College Dublin
2016-11 – 2021-09 · Human Immunodeficiency Virus
What this study did
Early phase / not applicable (62)
Chronic Hepatitis B
NCT00051090 · National Institute of Allergy and Infectious Diseases (NIAID)
— · HIV Infections, Hepatitis B
What this study did
NCT01139203 · Shanghai Jiao Tong University School of Medicine
2009-08 – 2012-12 · Liver Transplantation, Hepatitis B
What this study did
NCT01013272 · The University of Hong Kong
2007-06 – 2010-07 · Hepatitis B, Chronic
What this study did
Other / comorbidity
NCT07904520 · Bartın Unıversity
2025-05-01 – 2025-09-30 · Critical Illness, Pressure Injuries, Enteral Nutrition Intolerance in Critically Ill Patients
What this study did
NCT05477407 · Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida
2022-10-06 – 2025-01-01 · HIV Infections
What this study did
NCT04122404 · University of Southern Denmark
2019-10-14 – 2022-01-30 · Extrapulmonary Tuberculosis, Tuberculosis, Pulmonary, Human Immunodeficiency Virus (HIV), Acquired Immunodeficiency Syndrome
What this study did
NCT00001080 · National Institute of Allergy and Infectious Diseases (NIAID)
— · HIV Infections
What this study did
NCT02384395 · University of North Carolina, Chapel Hill
2015-09 – 2021-09-17 · HIV, Acute HIV Infection
What this study did
NCT00872872 · Thai Red Cross AIDS Research Centre
2008-05 – 2021-04 · NVP Plasma Level, NVP Related Mutation, 3TC Related Mutation
What this study did
NCT04600232 · Shanghai Public Health Clinical Center
2020-10 – 2021-02 · HIV Infections, Tuberculosis, Non-Tuberculous Mycobacterial Pneumonia
What this study did
NCT02911740 · University of Florida
2017-11 – 2018-08 · Tuberculosis, HIV, Histoplasmosis
What this study did
NCT03223402 · Cantonal Hospital of St. Gallen
2016-12-23 – 2018-05-31 · HIV Infections
What this study did
NCT01111929 · Assiut University
2009-01 – 2016-11 · Pregnancy During Breastfeeding, Lactational Amenorrhea Method
What this study did
NCT04813666 · Mansoura University
2015-01-01 – 2016-10-01 · TB - Tuberculosis HIV
What this study did
NCT01844297 · Peking Union Medical College
2013-05 – 2015-12 · AIDS/HIV PROBLEM
What this study did
NCT00006578 · National Institute of Allergy and Infectious Diseases (NIAID)
— · HIV Infections
What this study did
NCT01770730 · University of Cape Town
2013-01 – 2015-01 · Tuberculosis
What this study did
NCT01387022 · Centre for the AIDS Programme of Research in South Africa
2011-06 – 2014-11 · Antiretroviral Treatment Outcomes
What this study did
NCT01318096 · Yunnan AIDS Care Center
2011-03 – 2013-09 · HBV Coinfection, HIV Infections
What this study did
NCT01344148 · Shanghai Public Health Clinical Center
2009-02 – 2013-06 · AIDS
What this study did
NCT01693224 · Tuberculosis Clinical Diagnostics Research Consortium
2011-04 – 2013-02 · Tuberculosis, Tuberculosis, Pulmonary, Tuberculosis, Miliary
What this study did
NCT01525134 · Tuberculosis Clinical Diagnostics Research Consortium
2011-01 – 2012-04 · Tuberculosis, Tuberculosis, Pulmonary, Tuberculosis, Miliary
What this study did
NCT00091936 · National Institute of Allergy and Infectious Diseases (NIAID)
started 2009-08 · HIV Infections, Tuberculosis
What this study did
NCT00830856 · University of Zimbabwe
2006-10 – 2009-10 · Cryptococcal Meningitis, HIV Infections
What this study did
NCT00120510 · National Institute of Allergy and Infectious Diseases (NIAID)
2007-07 – 2009-09 · HIV Infections, Tuberculosis
What this study did
NCT00100568 · National Institute of Allergy and Infectious Diseases (NIAID)
2006-07 – 2009-06 · HIV Infections
What this study did
NCT00255840 · CIPRA SA
2006-07 – 2009-01 · HIV Infections
What this study did
NCT00006441 · National Institute of Allergy and Infectious Diseases (NIAID)
2003-02 – 2008-10 · HIV Infections
What this study did
NCT00002168 · Bristol-Myers Squibb
— · HIV Infections
What this study did
NCT00001075 · National Institute of Allergy and Infectious Diseases (NIAID)
est. completion 2007-07 · HIV Infections
What this study did
NCT00006617 · National Institute of Allergy and Infectious Diseases (NIAID)
est. completion 2007-06 · HIV Infections
What this study did
NCT00100594 · National Institute of Allergy and Infectious Diseases (NIAID)
2005-05 – 2007-05 · HIV Infections
What this study did
NCT00080522 · National Institute of Allergy and Infectious Diseases (NIAID)
2005-02 – 2007-01 · HIV Infections
What this study did
NCT00100581 · National Institute of Allergy and Infectious Diseases (NIAID)
est. completion 2007-01 · HIV Infections, Hepatitis C
What this study did
NCT00034086 · National Institute of Allergy and Infectious Diseases (NIAID)
est. completion 2006-06 · HIV Infections
What this study did
NCT00000922 · National Institute of Allergy and Infectious Diseases (NIAID)
est. completion 2006-06 · HIV Infections
What this study did
NCT00152061 · Stanford University
2005-01 – 2005-08 · HIV Infections
What this study did
NCT00002430 · Merck Sharp & Dohme LLC
— · HIV Infections
What this study did
NCT00002401 · Pharmacia and Upjohn
— · HIV Infections
What this study did
NCT00002108 · Glaxo Wellcome
— · HIV Infections
What this study did
NCT00002216 · Glaxo Wellcome
— · HIV Infections
What this study did
NCT00002203 · Glaxo Wellcome
— · HIV Infections
What this study did
NCT00002407 · Weill Medical College of Cornell University
— · HIV Infections
What this study did
NCT00002400 · Pharmacia and Upjohn
— · HIV Infections
What this study did
Used as active comparator (52)

Other programs' studies in which this drug was the registered active-comparator arm: a marker of standard-of-care status, not evidence of this drug's own progression.

Phase 3 (18)
Chronic Hepatitis B
NCT04704024 · University of Alabama at Birmingham
2021-09-03 – 2026-12-31 · Hepatitis B Infection
What this study did
NCT03236584 · Uijeongbu St. Mary Hospital
2015-09-01 – 2019-03-30 · Proportion of Patients With a Sustained Virological Response (Serum HBV DNA <20 IU/mL) at Week 48
What this study did
NCT01580202 · Seoul National University Hospital
2012-04 – 2017-06 · Malignancy, Hepatitis B
What this study did
NCT00076336 · Novartis Pharmaceuticals
2003-12 – 2009-12 · Hepatitis, Hepatitis B, Chronic, Cirrhosis
What this study did
NCT00316719 · GlaxoSmithKline
2006-01 – 2008-01 · Chronic Hepatitis B
What this study did
Other / comorbidity
NCT04303598 · Henan Genuine Biotech Co., Ltd.
2020-04-01 – 2022-08-01 · HIV-infection/Aids
What this study did
NCT04155554 · Azienda Ospedaliera Universitaria Senese
2020-01-29 – 2021-07 · HIV-1-infection
What this study did
NCT02469246 · Gilead Sciences
2015-06-29 – 2019-03-13 · HIV-1 Infection
What this study did
NCT02596334 · Centre Hospitalier Régional d'Orléans
2015-12-23 – 2018-06-23 · HIV
What this study did
NCT02369965 · Frontier Biotechnologies Inc.
2014-02-19 – 2018-04-02 · HIV Infections, AIDS
What this study did
NCT02219672 · Peking Union Medical College
2014-07 – 2017-07 · AIDS/HIV PROBLEM
What this study did
NCT00640263 · French National Agency for Research on AIDS and Viral Hepatitis
2009-12 – 2014-02 · HIV Infections
What this study did
NCT00405925 · Rijnstate Hospital
2003-03 – 2009-09 · HIV Infections
What this study did
NCT02181933 · Boehringer Ingelheim
1999-04 – 2001-01 · HIV Infections
What this study did
Phase 2/3 (2)
Other / comorbidity
NCT00424814 · ANRS, Emerging Infectious Diseases
2007-03 – 2012-11 · HIV Infections
What this study did
NCT00612898 · Avexa
2008-02 – 2010-01 · HIV Infections
What this study did
Phase 2 (6)
Other / comorbidity
NCT07202546 · ViiV Healthcare
2026-02-11 – 2032-07-09 · HIV Infections
What this study did
NCT07816250 · ViiV Healthcare
2026-10-19 – 2032-06-11 · HIV Infections
What this study did
NCT04900038 · ViiV Healthcare
2021-08-18 – 2023-05-11 · HIV Infections
What this study did
NCT00350272 · Alexion Pharmaceuticals, Inc.
2006-05 – 2009-04 · HIV Infections
What this study did
NCT00126880 · Avexa
2005-07 – 2008-01 · HIV Infections
What this study did
Phase 1/2 (2)
Other / comorbidity
NCT01718587 · General Hospital of Chinese Armed Police Forces
2012-11 – 2014-07 · Liver Cirrhosis
What this study did
NCT00312039 · Alexion Pharmaceuticals, Inc.
2006-03-31 – 2007-10-31 · HIV Infections
What this study did
Phase 4 (22)
Chronic Hepatitis B
NCT01491295 · Taipei Veterans General Hospital, Taiwan
2012-09 – 2019-12 · Chronic Hepatitis B
What this study did
NCT02482272 · Asan Medical Center
2015-05 – 2017-05 · Hepatitis B, Chronic
What this study did
NCT01732367 · Keimyung University Dongsan Medical Center
2012-11 – 2016-04 · Chronic Hepatitis B
What this study did
NCT00823550 · Yonsei University
2009-01 – 2015-07 · Hepatitis B, Chronic
What this study did
NCT00986778 · Bristol-Myers Squibb
2009-12 – 2014-06 · Hepatitis B, Chronic
What this study did
NCT00393484 · Bristol-Myers Squibb
2007-02 – 2013-09 · Chronic Hepatitis B
What this study did
NCT01023217 · Asan Medical Center
2009-11 – 2012-09 · Hepatitis B, Chronic
What this study did
NCT00625560 · Yonsei University
2008-02 – 2010-11 · Hepatitis B, Chronic
What this study did
NCT00625339 · Yonsei University
2008-02 – 2010-11 · Hepatitis B, Chronic
What this study did
NCT00637663 · Pusan National University Hospital
2008-02 – 2010-11 · Hepatitis B, Chronic
What this study did
NCT00710216 · University of Ulm
— · Hepatitis B, Chronic
What this study did
NCT00192595 · Kirby Institute
2004-01 – 2007-01 · HIV Infection, Hepatitis B Coinfection
What this study did
Other / comorbidity
NCT07678268 · Instituto Mexicano del Seguro Social
2025-07-10 – 2026-12-10 · HIV Infection, Antiretroviral Therapy, Lentivirus Infections
What this study did
NCT02470650 · Juan A. Arnaiz
2015-06 – 2017-10 · Patient Compliance, Antiretroviral Therapy Intolerance
What this study did
NCT01829802 · Pedro Cahn
2014-05 – 2017-10 · Chronic Infection With HIV
What this study did
NCT00865007 · Fundacion SEIMC-GESIDA
2008-12 – 2012-09 · HIV Infection, Lipodystrophy, HIV Infections
What this study did
NCT00724711 · Gilead Sciences
2008-07 – 2011-04 · HIV Infection
What this study did
NCT00627055 · The HIV Netherlands Australia Thailand Research Collaboration
2008-05 – 2010-11 · HIV Infections
What this study did
NCT00324649 · Gilead Sciences
2006-05 – 2008-09 · HIV-1
What this study did
Early phase / not applicable (2)
Other / comorbidity
NCT03405194 · Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic
2018-05-01 – 2020-07-01 · HIV/AIDS
What this study did
Appears in other studies (14)

Studies that reference this drug without giving it an intervention arm of its own: other formulations' programs, background therapy, or registry-search bleed.

Phase 3 (3)
Chronic Hepatitis B
NCT00095121 · Gilead Sciences
2004-06 – 2010-04 · Chronic Hepatitis B
What this study did
Other / comorbidity
NCT06138600 · University of Witwatersrand, South Africa
2023-11-01 – 2026-01-31 · HIV Infections
What this study did
NCT01936233 · Fudan University
2013-08 – 2023-12 · Hepatocellular Carcinoma, Recurrence
What this study did
Phase 2 (4)
Other / comorbidity
NCT07871552 · The University of Texas Health Science Center, Houston
2026-10-30 – 2028-10-15 · Epigenetic Aging
What this study did
NCT06338826 · ANRS, Emerging Infectious Diseases
2025-02-01 – 2027-09-30 · HIV Infections, HBV Coinfection
What this study did
NCT04109183 · Henan Genuine Biotech Co., Ltd.
2017-10-10 – 2019-03-06 · AIDS
What this study did
Phase 4 (3)
Other / comorbidity
NCT00385957 · Hospital Clinic of Barcelona
— · HIV Infections
What this study did
NCT00872417 · Peking Union Medical College
2009-03 – 2010-12 · Acquired Immune Deficiency Syndrome, HIV Infections
What this study did
NCT00389194 · International Antiviral Therapy Evaluation Center
2006-04 – 2008-10 · HIV Infections
What this study did
Early phase / not applicable (4)
Other / comorbidity
NCT03394196 · University of Washington
2018-07-04 – 2020-05-31 · HIV-2 Infection
What this study did
NCT01844310 · Peking Union Medical College
2013-05 – 2015-12 · AIDS/HIV PROBLEM
What this study did
NCT01583439 · Harvard School of Public Health (HSPH)
2012-09 – 2013-09 · HIV Infections
What this study did
NCT00100646 · The Wistar Institute
2007-03 – 2010-03 · HIV Infections
What this study did

Competitive landscape

7 other tracked programmes target this mechanism, none of them ahead of this one.

This drug's own stage for Chronic Hepatitis B: Approved. Competitors below are sorted furthest-along first.

DrugStageModalityMechanismEvidence signalReported efficacygraded featured trials
Lamivudine (Epivir-HBV): this drugApprovedSmall moleculeHBV polymerase (reverse transcriptase)not yet gradedNo reviewed efficacy summary in this indication
Entecavir (Baraclude)ApprovedSmall moleculeHBV polymerase (reverse transcriptase)not yet gradedNo reviewed efficacy summary in this indication
Hepatitis B Immune Globulin (HepaGam B)ApprovedProtein / enzyme therapeuticHBsAgnot yet gradedNo reviewed efficacy summary in this indication
Interferon Alfa-2b (Intron A)ApprovedBiologic (subtype unspecified)Type I interferon receptornot yet gradedNo reviewed efficacy summary in this indication
Peginterferon Alfa-2a (Pegasys)Approved—Type I interferon receptorPartial signalFeatured results are non-efficacy only in this race
Tenofovir Alafenamide (Vemlidy)ApprovedSmall moleculeHBV polymerase (reverse transcriptase)Reliable signalFeatured results are non-efficacy only in this race
Tenofovir Disoproxil Fumarate (Viread)ApprovedSmall moleculeHIV reverse transcriptase (RT)Reliable signal
NCT00116805: Percentage of Participants With HBV DNA < 400 Copies/mL and Histological Improvement (2-point Reduction in Knodell Necroinflammatory Score Without Worsening in Knodell Fibrosis Score) at Week 48 (Baseline; Week 48): TDF-TDF 66.5 percentage of participants | ADV 10 mg 12.2 percentage of participants
NCT00117676: Percentage of Participants With HBV DNA < 400 Copies/mL and Histological Improvement (2-point Reduction in Knodell Necroinflammatory Score Without Worsening in Knodell Fibrosis Score) at Week 48 (Baseline; Week 48): TDF-TDF — Yes: 70.8 percentage of participants; No: 29.2 percentage of participants | ADV-TDF — Yes: 48.8 percentage of participants; No: 51.2 percentage of participants
Besifovir Dipivoxil (Besivo)Phase 3Small moleculeHBV polymerase (reverse transcriptase)Partial signal
NCT01937806: Primary endpoint at week 48: 80.9% with besifovir vs 84.9% with tenofovir disoproxil fumarate met the virologic response endpoint, showing non-inferiority (Ahn et al., Clin Gastroenterol Hepatol 2019).
Hepatitis B Immune Globulin (I.V.-Hepabig)Phase 3Polyclonal Antibody (human Hepatitis B Immunoglobulin)HBsAgnot yet gradedNo reviewed efficacy summary in this indication
Tenofovir Amibufenamide (Hengmu)Phase 3Small moleculeHBV polymerase (reverse transcriptase)not yet gradedNo reviewed efficacy summary in this indication
TQA3605Phase 3—HBV core proteinnot yet gradedNo reviewed efficacy summary in this indication
TVAX-008Phase 3VaccineHepatitis B virus antigens (HBsAg + HBcAg)not yet gradedNo reviewed efficacy summary in this indication
AHB-171Phase 2RNA / oligonucleotideHBV RNAnot yet gradedNo reviewed efficacy summary in this indication
Daplusiran / TomligisiranPhase 2RNA / oligonucleotideHBV RNA (X and S transcripts)not yet gradedNo reviewed efficacy summary in this indication
EnvafolimabPhase 2Monoclonal antibodyPD-L1not yet gradedNo reviewed efficacy summary in this indication
HepalatidePhase 2PeptideNTCPnot yet gradedNo reviewed efficacy summary in this indication
Libevitug (HH-003)Phase 2Monoclonal antibodyHBV/HDV large envelope protein (PreS1 domain)not yet gradedNo reviewed efficacy summary in this indication
MetacavirPhase 2Small moleculeHBV reverse transcriptase (nucleoside analog)not yet gradedNo reviewed efficacy summary in this indication
REP 2139-MgPhase 2—HBsAg release (nucleic acid polymer)not yet gradedNo reviewed efficacy summary in this indication
T101Phase 2Biologic (subtype unspecified)HBV core, polymerase and envelope antigensnot yet gradedNo reviewed efficacy summary in this indication
TQA3810Phase 2—TLR8not yet gradedNo reviewed efficacy summary in this indication
CRMA-1001Phase 1/2Gene therapy / editingHBV genome (cccDNA and integrated DNA)not yet gradedNo reviewed efficacy summary in this indication
HepadvaxPhase 1/2VaccineHBsAg (PreS) immunizationnot yet gradedNo reviewed efficacy summary in this indication
Human Serum Albumin / Interferon Alpha2b Fusion ProteinPhase 1/2Biologic (subtype unspecified)Type I interferon receptornot yet gradedNo reviewed efficacy summary in this indication
LW231Phase 1/2——not yet gradedNo reviewed efficacy summary in this indication
PA1010Phase 1/2——not yet gradedNo reviewed efficacy summary in this indication
TQA3038Phase 1/2——not yet gradedNo reviewed efficacy summary in this indication
ACT201Phase 1RNA / oligonucleotideHBsAgnot yet gradedNo reviewed efficacy summary in this indication
CB06-036Phase 1—TLR8not yet gradedNo reviewed efficacy summary in this indication
DA-2803Phase 1——not yet gradedNo reviewed efficacy summary in this indication
Entecavir (Cavir)
Phase 1(overall)
Small moleculeHBV polymerase (reverse transcriptase)not yet gradedNo reviewed efficacy summary in this indication
HECN30227Phase 1——not yet gradedNo reviewed efficacy summary in this indication
SA1211Phase 1RNA / oligonucleotideHepatitis B virus RNA (dual-target siRNA)not yet gradedNo reviewed efficacy summary in this indication
TVAX-028Phase 1——not yet gradedNo reviewed efficacy summary in this indication
Adefovir Dipivoxil (Hepsera)DiscontinuedSmall moleculeHBV polymerase (reverse transcriptase)not yet gradedNo reviewed efficacy summary in this indication
Obeticholic Acid (Ocaliva)Discontinued—FXRnot yet gradedNo reviewed efficacy summary in this indication
PamrevlumabDiscontinuedMonoclonal antibodyCTGFnot yet gradedNo reviewed efficacy summary in this indication
Telbivudine (Tyzeka)Discontinued—HBV polymerase (reverse transcriptase)Partial signal
NCT00076336: Protocol composite at week 52 (HBV DNA <10,000 copies/mL, normal ALT, Child-Turcotte-Pugh score improved or stable), telbivudine vs lamivudine, ITT missing=failure: 56.2% vs 54.0%, non-inferiority not achieved (Chan et al., Aliment Pharmacol Ther 2012). missed

Upcoming events

(19 total)

Development was discontinued (source ↗). ClinicalTrials.gov still lists the estimated primary-completion dates below; they are not pending readouts.

2026 (2)
December 2026 (2)
Phase 4HIV, HIV-1RecruitingProgramme discontinued
Est. primary completion 2026-12 · NCT06967753 · CT.gov ↗
What to watch
Phase 4HIV Infection, Metabolic Syndrome, Antiretroviral TreatmentRecruitingProgramme discontinued
Est. primary completion 2026-12-01 · NCT07031063 · CT.gov ↗
What to watch
2027 (6)
January 2027 (1)
Phase 2HIV-1-infectionRecruitingProgramme discontinued
Est. primary completion 2027-01-15 · NCT06774872 · CT.gov ↗
What to watch
June 2027 (2)
Phase 2Rett SyndromeEnrolling by invitationProgramme discontinued
Est. primary completion 2027-06 · NCT07640503 · CT.gov ↗
What to watch
Phase 1Smokers, Former SmokersActive not recruitingProgramme discontinued
Est. primary completion 2027-06-15 · NCT07058974 · CT.gov ↗
What to watch
July 2027 (1)
Phase 2Extensive Stage Lung Small Cell CarcinomaRecruitingProgramme discontinued
Est. primary completion 2027-07-01 · NCT04696575 · CT.gov ↗
What to watch
August 2027 (1)
Phase 4HIV (Human Immunodeficiency Virus), SleepNot yet recruitingProgramme discontinued
Est. primary completion 2027-08-31 · NCT07673965 · CT.gov ↗
What to watch
December 2027 (1)
Phase 3HIV - Human Immunodeficiency Virus, Obesity, Overweight and/or ObesityRecruitingProgramme discontinued
Est. primary completion 2027-12-05 · NCT07075146 · CT.gov ↗
What to watch
2028 (8)
January 2028 (2)
Phase 3HIV-1-infectionRecruitingProgramme discontinued
Est. primary completion 2028-01 · NCT06203132 · CT.gov ↗
What to watch
Phase 3Tuberculosis, HIVRecruitingProgramme discontinued
Est. primary completion 2028-01-31 · NCT06497465 · CT.gov ↗
What to watch
April 2028 (1)
Phase 4HIV-1-infectionRecruitingProgramme discontinued
Est. primary completion 2028-04-30 · NCT07357584 · CT.gov ↗
What to watch
June 2028 (1)
Phase 4HIV, Art Therapy, TB - TuberculosisNot yet recruitingProgramme discontinued
Est. primary completion 2028-06 · NCT07631897 · CT.gov ↗
What to watch
October 2028 (1)
Phase 4HIV-1-infectionRecruitingProgramme discontinued
Est. primary completion 2028-10-15 · NCT07616739 · CT.gov ↗
What to watch
November 2028 (2)
Phase 2Systemic Lupus ErythematosusNot yet recruitingProgramme discontinued
Est. primary completion 2028-11-01 · NCT06356740 · CT.gov ↗
What to watch
Phase 2Human Immunodeficiency Virus (HIV) InfectionRecruitingProgramme discontinued
Est. primary completion 2028-11-12 · NCT04375800 · CT.gov ↗
What to watch
December 2028 (1)
Phase 2/3Osteoarthritis, KneeRecruitingProgramme discontinued
Est. primary completion 2028-12 · NCT05517434 · CT.gov ↗
What to watch
2029 (2)
April 2029 (1)
Phase 1High Grade GliomaRecruitingProgramme discontinued
Est. primary completion 2029-04-30 · NCT06428045 · CT.gov ↗
What to watch
June 2029 (1)
Phase 3HIV InfectionNot yet recruitingProgramme discontinued
Est. primary completion 2029-06 · NCT07792096 · CT.gov ↗
What to watch
2032 (1)
September 2032 (1)
Phase 3HIV InfectionsRecruitingProgramme discontinued
Est. primary completion 2032-09-14 · NCT07393659 · CT.gov ↗
What to watch

See the full readout calendar ↗